Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

PALVELLA THERAPEUTICS, INC.

PVLA · Nasdaq · CIK 0001583648 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

57 Form 4 transaction lines observed in the same window
45 sales · 12 option, withholding, award, gift or other lines

Last qualifying purchase2026-02-27 · JENKINS GEORGE M · $500.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Goin KathleenChief Operating Officer
○▼○▼○▼○▼○▼
JENKINS GEORGE MDirector
▼▼▼▼▼▼
KIRITSY CHRISTOPHER PDirector
○▼
Korenberg Matthew ECFO, Treasurer
○
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-02-27 · JENKINS GEORGE M.

Recent Form 4 activity

2Purchases
60Sales
24Other Form 4 lines
17SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING45 sale line(s) · context only
OTHER12 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,524,140
Previous report
2,325,699
Avg daily volume
236,256
Days to cover
10.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-02-27JENKINS GEORGE MPurchase (P)Common Stock4,000USD 125.00USD 500,000SEC filing ↗
2026-02-27HERON ELAINE JPurchase (P)Common Stock2,400USD 125.00USD 300,000SEC filing ↗
2025-04-09JENKINS GEORGE MPurchase (P)Common Stock4,990USD 20.20USD 100,797SEC filing ↗
2024-12-18JENKINS GEORGE MPurchase (P)Common Stock4,000USD 12.93USD 51,720SEC filing ↗
2024-08-12ADAR1 Capital Management, LLC; ADAR1 Partners, LPPurchase (P)Common Stock3,000USD 15.88USD 47,640SEC filing ↗
2024-08-09ADAR1 Capital Management, LLC; ADAR1 Partners, LPPurchase (P)Common Stock3,000USD 14.89USD 44,670SEC filing ↗
2024-08-07GERAGHTY JAMES APurchase (P)Series F Preferred Stock, par value $0.001 per share1USD 1.00USD 1SEC filing ↗
2023-05-25KIRITSY CHRISTOPHER PPurchase (P)Common Stock10,000USD 0.85USD 8,500SEC filing ↗
2022-05-13Demuth TimPurchase (P)Common Stock6,000USD 1.71USD 10,260SEC filing ↗

Form 4 evidence

86 transaction lines in the latest 365-day window; 103 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14JENKINS GEORGE MSale (S)Common Stock7,174USD 123.49USD 885,914SEC filing ↗
2026-10-13JENKINS GEORGE MSale (S)Common Stock7,174USD 130.36USD 935,232SEC filing ↗
2026-10-12JENKINS GEORGE MSale (S)Common Stock13,152USD 133.69USD 1,758,330SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14JENKINS GEORGE MSale (S)Common Stock7,174USD 123.49USD 885,914SEC filing ↗
2026-10-13JENKINS GEORGE MSale (S)Common Stock7,174USD 130.36USD 935,232SEC filing ↗
2026-10-12JENKINS GEORGE MSale (S)Common Stock13,152USD 133.69USD 1,758,330SEC filing ↗
2026-09-16Goin KathleenSale (S)Common Stock4,302USD 152.24USD 654,917SEC filing ↗
2026-09-16Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-09-15JENKINS GEORGE MSale (S)Common Stock1,777USD 150.15USD 266,809SEC filing ↗
2026-09-14JENKINS GEORGE MSale (S)Common Stock13,352USD 151.96USD 2,028,918SEC filing ↗
2026-09-11JENKINS GEORGE MSale (S)Common Stock12,371USD 151.28USD 1,871,463SEC filing ↗
2026-09-02KIRITSY CHRISTOPHER PSale (S)Common Stock313USD 157.00USD 49,141SEC filing ↗
2026-09-02KIRITSY CHRISTOPHER POption exercise / conversion (M)Common Stock313USD 127.20USD 39,814SEC filing ↗
2026-08-19Goin KathleenSale (S)Common Stock4,302USD 152.21USD 654,796SEC filing ↗
2026-08-19Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-07-15Goin KathleenSale (S)Common Stock4,302USD 149.28USD 642,190SEC filing ↗
2026-07-15Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-06-17Goin KathleenSale (S)Common Stock4,302USD 110.73USD 476,369SEC filing ↗
2026-06-17Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-06-12Korenberg Matthew EOption exercise / conversion (M)Common Stock1,000USD 13.60USD 13,600SEC filing ↗
2026-05-20Goin KathleenSale (S)Common Stock4,302USD 110.56USD 475,647SEC filing ↗
2026-05-20Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-04-15Goin KathleenSale (S)Common Stock4,302USD 127.24USD 547,397SEC filing ↗
2026-04-15Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-03-18Goin KathleenSale (S)Common Stock4,302USD 117.99USD 507,607SEC filing ↗
2026-03-18Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-02-27JENKINS GEORGE MPurchase (P)Common Stock4,000USD 125.00USD 500,000SEC filing ↗
2026-02-27HERON ELAINE JPurchase (P)Common Stock2,400USD 125.00USD 300,000SEC filing ↗
2026-02-18Goin KathleenSale (S)Common Stock4,302USD 79.40USD 341,580SEC filing ↗
2026-02-18Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2026-01-21Goin KathleenSale (S)Common Stock4,302USD 97.63USD 419,983SEC filing ↗
2026-01-21Goin KathleenOption exercise / conversion (M)Common Stock4,302USD 8.11USD 34,883SEC filing ↗
2025-12-17Goin KathleenSale (S)Common Stock4,302USD 96.47USD 415,014SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPVLA
CIK0001583648
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history103 transaction lines from 2020-07-21 to 2026-10-14
11 P purchase lines · 63 S sale lines · 29 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.